机构:[1]Capital Univ Med Sci, Beijing Xuan Wu Hosp, Neurobiochem Lab, Beijing 100053, Peoples R China首都医科大学宣武医院[2]Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA
The objective of this study was to find out which N-terminal segment/s of amyloid precursor protein (APP) has any neurotrophic properties, since soluble APP-alpha (sAPP-alpha) has neurotrophic effects. We investigated neurotrophic properties of eight peptide segments of N-terminal APP. The APP(63-73) was able to enhance neuronal growth; augment axonal and cell body growth in human neuroblastoma cell line. SH-SY5Y Neurotrophic effects of chronic APP(63-73) treatment were assessed in vivo using streptozotocin-induced diabetes and ovariectomized rats, Thus, this study demonstrated that APP(63-73) peptide has neurotrophic effects both in vivo and in vitro.
第一作者机构:[1]Capital Univ Med Sci, Beijing Xuan Wu Hosp, Neurobiochem Lab, Beijing 100053, Peoples R China[2]Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA
通讯作者:
通讯机构:[1]Capital Univ Med Sci, Beijing Xuan Wu Hosp, Neurobiochem Lab, Beijing 100053, Peoples R China
推荐引用方式(GB/T 7714):
Wang R,Zhang JY,Yang F,et al.A novel neurotrophic peptide: APP(63-73)[J].NEUROREPORT.2004,15(17):2677-2680.doi:10.1097/00001756-200412030-00025.